Updated Efficacy and Safety Data from the Phase 2 NP28761 Study of Alectinib in ALK-Positive Non-Small-Cell Lung CancerD. Ross Camidge,Shirish Gadgeel, Sai-Hong Ou,Leena Gandhi,Gregory Riely,Jeremy Cetnar,Howard West,Mark Socinski,Alberto Chiappori,Tarek Mekhail,Bo Chao,Hossein Borghaei,Kathryn Gold,Walter Bordogna,Bogdana Balas,Johannes Noe,Sophie Golding,Ali Zeaiter,Alice ShawJOURNAL OF THORACIC ONCOLOGY（2017）引用 10|浏览10暂无评分关键词Alectinib,NSCLC,US,ALK-inhibitorAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
